WntResearch
Medeon Science Park
Malmö
SE-205-12
Tel: 46-72-702-4694
Website: http://www.wntresearch.com
Email: hl@wntresearch.com
About WntResearch
WntResearch is developing a new type of cancer treatment based on pioneering research, which shows that the endogenous protein Wnt-5a plays a crucial role for tumour cells’ ability to relocate and spread in the body. Most patients that die of cancer do so not due to the primary tumour, but due to metastases. The need for a specific treatment to counteract metastasis is therefore in high demand.YEAR FOUNDED:
2007
LEADERSHIP:
CEO: Henrik Lawaetz
CFO: Per-Ola Forsberg
CSO: Tommy Andersson
CTO: Dennis Henriksen
CLINICAL TRIAL:
Please click here for clinical trial information.
2 articles about WntResearch
-
WntResearch Increases Resources for Out-licensing of Foxy-5
8/30/2019
WntResearch and The Sage Group have initiated a collaboration to accelerate the process of identifying and engaging potential partners prior to readout of the on-going Phase 2 study with Foxy-5.
-
WntResearch Announces Positive Results From Clinical Study With Drug Candidate Foxy-5
3/21/2017